Development of antibiotic activity profile screening for the classification and discovery of natural product antibiotics

Chemistry and Biology

Volumn 19, Issue 11, 2012, Pages 1483-1495

  Wong, Weng Ruh ^a,b   Oliver, Allen G ^c   Linington, Roger G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Kemeneterian Sains Teknologi dan Inovasi   (Malaysia)

^c UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; ANTIBIOTIC AGENT; ARROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; DACTINOMYCIN; DOXORUBICIN; DOXYCYCLINE; EPIRUBICIN; FLORFENICOL; GENTAMICIN; IDARUBICIN; LEVOFLOXACIN; LINCOMYCIN; MITHRAMYCIN; NATURAL PRODUCT; NITROFURANTOIN; NORFLOXACIN; ORNIDAZOLE; PENICILLIN G; RIFAMPICIN; SPARFLOXACIN; SPIRAMYCIN; STREPTOMYCIN; TETRACYCLINE; THIAMPHENICOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALINOMYCIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG CLASSIFICATION; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG PURIFICATION; DRUG SCREENING; DRUG STRUCTURE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CLUSTER ANALYSIS; DRUG EVALUATION, PRECLINICAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MOLECULAR SEQUENCE DATA; NAPHTHOQUINONES; RNA, RIBOSOMAL, 16S;

BACTERIA (MICROORGANISMS);

EID: 84870043139     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2012.09.014     Document Type: Article

References (39)

1. M. Barber, and P.M. Waterworth Penicillinase-resistant penicillins and cephalosporins BMJ 2 1964 344 349
2. E. Bishburg, and K. Bishburg Minocycline - an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii Int. J. Antimicrob. Agents 34 2009 395 401
3. J.W. Blunt, M.H.G. Munro, and H. Laatsch AntiMarin Database, University of Canterbury 2009 New Zealand and University of Göttingen, Göttingen, Germany Christchurch
4. H.W. Boucher, G.H. Talbot, J.S. Bradley, J.E. Edwards, D. Gilbert, L.B. Rice, M. Scheld, B. Spellberg, and J. Bartlett Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America Clin. Infect. Dis. 48 2009 1 12
5. P.F. Chan, D.J. Holmes, and D.J. Payne Finding the gems using genomic discovery: antibacterial drug discovery strategies - the successes and the challenges Drug Discov. Today Ther. Strateg. 1 2004 519 527
6. R.D. Charan, G. Schlingmann, V.S. Bernan, X. Feng, and G.T. Carter Fumaquinone, a new prenylated naphthoquinone from Streptomyces fumanus J. Antibiot. (Tokyo) 58 2005 271 274
7. Y. Chung, R.S. Quan, H.Y. Chang, S.H. Kwon, S.-J. Kim, Y.-S. Im, K.S. Shin, K.-D. Park, H.-K. Lee, and J.-K. Choi Antibacterial activity of novel naphthoquinones derivatives Genes & Genomics. 31 2009 429 434
8. J. Clardy, M.A. Fischbach, and C.T. Walsh New antibiotics from bacterial natural products Nat. Biotechnol. 24 2006 1541 1550
9. M.J.L. de Hoon, S. Imoto, J. Nolan, and S. Miyano Open source clustering software Bioinformatics 20 2004 1453 1454
10. K. Drlica, and X. Zhao DNA gyrase, topoisomerase IV, and the 4-quinolones Microbiol. Mol. Biol. Rev. 61 1997 377 392
11. J.A. Dunkle, L. Xiong, A.S. Mankin, and J.H.D. Cate Structures of the Escherichia coli ribosome with antibiotics bound near the peptidyl transferase center explain spectra of drug action Proc. Natl. Acad. Sci. USA 107 2010 17152 17157
12. M.A. Fischbach, and C.T. Walsh Antibiotics for emerging pathogens Science 325 2009 1089 1093
13. S. Funayama, M. Ishibashi, Y. Anraku, K. Komiyama, and S. Omura Structures of novel antibiotics, furaquinocins A and B Tetrahedron Lett. 30 1989 7427 7430
14. O. Genilloud, I. González, O. Salazar, J. Martín, J.R. Tormo, and F. Vicente Current approaches to exploit actinomycetes as a source of novel natural products J. Ind. Microbiol. Biotechnol. 38 2011 375 389
15. A. Giedraitiene, A. Vitkauskiene, R. Naginiene, and A. Pavilonis Antibiotic resistance mechanisms of clinically important bacteria Medicina (Kaunas) 47 2011 137 146
16. K. Hong, A.H. Gao, Q.Y. Xie, H. Gao, L. Zhuang, H.P. Lin, H.P. Yu, J. Li, X.S. Yao, M. Goodfellow, and J.S. Ruan Actinomycetes for marine drug discovery isolated from mangrove soils and plants in China Mar. Drugs 7 2009 24 44
17. J.-F. Hu, E. Garo, H.-D. Yoo, P.A. Cremin, L. Zeng, M.G. Goering, M. O'Neil-Johnson, and G.R. Eldridge Application of capillary-scale NMR for the structure determination of phytochemicals Phytochem. Anal. 16 2005 127 133
18. M. Ishibashi, S. Funayama, Y. Anraku, K. Komiyama, and S. Omura Novel antibiotics, furaquinocins C, D, E, F, G and H J. Antibiot. (Tokyo) 44 1991 390 395
19. J.J. Kessl, P. Hill, B.B. Lange, S.R. Meshnick, B. Meunier, and B.L. Trumpower Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc(1) complex of Saccharomyces cerevisiae J. Biol. Chem. 279 2004 2817 2824
20. M.A. Kohanski, D.J. Dwyer, and J.J. Collins How antibiotics kill bacteria: from targets to networks Nat. Rev. Microbiol. 8 2010 423 435
21. M. Lambert, J.-L. Wolfender, D. Staerk, S.B. Christensen, K. Hostettmann, and J.W. Jaroszewski Identification of natural products using HPLC-SPE combined with CapNMR Anal. Chem. 79 2007 727 735
22. G. Lang, N.A. Mayhudin, M.I. Mitova, L. Sun, S. van der Sar, J.W. Blunt, A.L.J. Cole, G. Ellis, H. Laatsch, and M.H.G. Munro Evolving trends in the dereplication of natural product extracts: new methodology for rapid, small-scale investigation of natural product extracts J. Nat. Prod. 71 2008 1595 1599
23. Y. Lin, S. Schiavo, J. Orjala, P. Vouros, and R. Kautz Microscale LC-MS-NMR platform applied to the identification of active cyanobacterial metabolites Anal. Chem. 80 2008 8045 8054
24. N. Matsumoto, T. Tsuchida, M. Maruyama, N. Kinoshita, Y. Homma, H. Iinuma, T. Sawa, M. Hamada, T. Takeuchi, N. Heida, and T. Yoshioka Lactonamycin, a new antimicrobial antibiotic produced by Streptomyces rishiriensis MJ773-88K4. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities J. Antibiot. (Tokyo) 52 1999 269 275
25. M.I. Mitova, A.C. Murphy, G. Lang, J.W. Blunt, A.L.J. Cole, G. Ellis, and M.H.G. Munro Evolving trends in the dereplication of natural product extracts. 2. The isolation of chrysaibol, an antibiotic peptaibol from a New Zealand sample of the mycoparasitic fungus Sepedonium chrysospermum J. Nat. Prod. 71 2008 1600 1603
26. V.P. Papageorgiou, A.N. Assimopoulou, E.A. Couladouros, D. Hepworth, and K.C. Nicolaou The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products Angew. Chem. Int. Ed. 38 1999 270 301
27. D.J. Payne, M.N. Gwynn, D.J. Holmes, and D.L. Pompliano Drugs for bad bugs: confronting the challenges of antibacterial discovery Nat. Rev. Drug Discov. 6 2007 29 40
28. L.R. Peterson Bad bugs, no drugs: no ESCAPE revisited Clin. Infect. Dis. 49 2009 992 993
29. A. Riffel, L.F. Medina, V. Stefani, R.C. Santos, D. Bizani, and A. Brandelli In vitro antimicrobial activity of a new series of 1,4-naphthoquinones Braz. J. Med. Biol. Res. 35 2002 811 818
30. A.I. Saeed, V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Klapa, T. Currier, and M. Thiagarajan TM4: a free, open-source system for microarray data management and analysis Biotechniques 34 2003 374 378
31. K. Shin-ya, S. Imai, K. Furihata, Y. Hayakawa, Y. Kato, G.D. Vanduyne, J. Clardy, and H. Seto Isolation and structural elucidation of an antioxidative agent, naphterpin J. Antibiot. (Tokyo) 43 1990 444 447
32. L.L. Silver Challenges of antibacterial discovery Clin. Microbiol. Rev. 24 2011 71 109
33. M.E. Smoot, K. Ono, J. Ruscheinski, P.-L. Wang, and T. Ideker Cytoscape 2.8: new features for data integration and network visualization Bioinformatics 27 2011 431 432
34. Spellberg, B. (2010). Antibiotic resistance: promoting critically needed antibiotic research and development and appropriate use ('stewardship') of these precious drugs. (http://www.idsociety.org/uploadedFiles/IDSA/Policy-and- Advocacy/Current-Topics-and-Issues/Advancing-Product-Research-and-Development/ Antimicrobials/Statements/IDSATestimony%20Final%20with%20references%20060310. pdf#search= %22Brad%20Spellberg%20stewardship%20antibiotic%20resistance%20june%202010%).
35. S.N. Sunassee, and M.T. Davies-Coleman Cytotoxic and antioxidant marine prenylated quinones and hydroquinones Nat. Prod. Rep. 29 2012 513 535
36. L. Verbist In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity Antimicrob. Agents Chemother. 13 1978 349 357
37. A. Voskiene, B. Sapijanskaite, V. Mickevičius, K. Kantminiene, M. Stasevych, O. Komarovska-Porokhnyavets, R. Musyanovych, and V. Novikov Synthesis, chemical properties, and antimicrobial activity of 2- and 2,3-substituted [(tetrahydro-2,4-dioxopyrimidin-1(2H)-yl)phenoxy]naphthalene-1, 4-diones Monatsh. Chem. 142 2011 529 537
38. C. Walsh Where will new antibiotics come from? Nat. Rev. Microbiol. 1 2003 65 70
39. J.-L. Wolfender, P.J. Eugster, N. Bohni, and M. Cuendet Advanced methods for natural product drug discovery in the field of nutraceuticals Chimia (Aarau) 65 2011 400 406